Zobrazeno 1 - 10
of 11
pro vyhledávání: '"R Andrew James"'
Autor:
R. Andrew James, Lorna C Gilligan, Bijay Vaidya, Anna L. Mitchell, Catherine Napier, Krishna Chatterjee, Earn H Gan, Simon H. S. Pearce, D. Aled Rees, Simon Ashwell, Carla Moran, Wiebke Arlt, Yaasir Mamoojee
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Context In autoimmune Addison’s disease (AAD), exogenous glucocorticoid (GC) therapy is an imperfect substitute for physiological GC secretion. Patients on long-term steroid replacement have increased morbidity, reduced life expectancy, and poorer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b4bb8fe740ad4bd59871179fd6425f
Autor:
R. Dermot G. Neely, Christopher Boot, Fiona Green, Vasileios Tsatlidis, Fraser Gibb, R Andrew James
Publikováno v:
Endocrine Abstracts.
Autor:
Whitney W. Woodmansee, David F. Gordon, William M. Wood, Suzanne R. Lewis, E. Chester Ridgway, R. Andrew James
Publikováno v:
Endocrinology. 140:5598-5608
Somatostatin is a peptide hormone whose actions are mediated by five somatostatin receptor subtypes (sst1–5). In the pituitary, somatostatin inhibits TSH release from thyrotropes and GH release from somatotropes. We have shown that sst5 transcripts
Autor:
E. Chester Ridgway, David F. Gordon, Suzanne R. Lewis, R. Andrew James, Michael T. McDermott, Bryan R. Haugen, William M. Wood
Publikováno v:
Journal of Biological Chemistry. 272:24339-24347
The molecular determinants governing cell-specific expression of the thyrotropin (TSH) beta-subunit gene in pituitary thyrotropes are not well understood. The P1 region of the mouse TSHbeta promoter (-133 to -88) region interacts with Pit-1 and an ad
Autor:
R. Andrew James, David F. Gordon, Friedrich Raulf, Christian Bruns, E. Chester Ridgway, Janet M. Dowding, William M. Wood, Virginia D. Sarapura
Publikováno v:
Endocrinology. 138:719-724
Following the protracted hypothyroid state, treatment with thyroid hormone will induce a decline in TSH and reduce thyrotrope hyperplasia. Somatostatin is a hypothalamic peptide that has been implicated in the negative regulation of TSH secretion in
Autor:
Earn H, Gan, Katie, MacArthur, Anna L, Mitchell, Beverly A, Hughes, Petros, Perros, Stephen G, Ball, R Andrew, James, Richard, Quinton, Shu, Chen, Jadwiga, Furmaniak, Wiebke, Arlt, Simon H S, Pearce
Publikováno v:
The Journal of clinical endocrinology and metabolism. 99(1)
Despite lifelong steroid hormone replacement, there is excess morbidity and mortality associated with autoimmune Addison's disease. In health, adrenocortical cells undergo continuous self-renewal from a population of subcapsular progenitor cells, und
Publikováno v:
A Case-Based Guide to Clinical Endocrinology ISBN: 9781588298157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::481c6a04a2807f1b9fce87c230c20737
https://doi.org/10.1007/978-1-60327-103-5_19
https://doi.org/10.1007/978-1-60327-103-5_19
Autor:
Andrew Advani, R. Andrew James, Suresh Vaikkakara, Ebaa Al-Ozairi, Stephen Ball, Richard Quinton, Eelin Lim
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 24(2)
An androgen-secreting tumor needs to be excluded in any woman with severe hyperandrogenism. We sought to characterize patients with biochemical hyperandrogenism in respect of tumor versus non-tumor etiologies, explore possible links between non-tumor
Autor:
Richard Quinton, R. Andrew James, Tim Cheetham, Jocelyn Davies, Simon H. S. Pearce, Heather J. Cordell, Peter T. Donaldson, Alison Sutherland, Petros Perros, Christine Walker, Catherine J. Owen, Suresh Vaikkakara
Publikováno v:
The Journal of clinical endocrinology and metabolism. 92(8)
Context: A recent large-scale analysis of nonsynonymous coding polymorphisms showed strong evidence that an alanine to threonine amino acid change at codon 946 of the interferon-induced helicase (IFIH1) gene (SNP ID rs1990760) was associated with typ
Autor:
R. Andrew James, John J. Gilroy
Publikováno v:
Treatments in endocrinology. 1(3)
Somatostatin peptide analogs have revolutionized the medical treatment of patients with acromegaly. More recent deep intramuscular depot preparations have further improved control, with consistent suppression of growth hormone secretion and optimal l